These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18297448)

  • 41. Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases.
    Seo YE; Ryu H; Oh JJ; Jeong SJ; Hwang SI; Lee HJ; Hong SK; Byun SS; Lee SE; Lee S
    Surg Infect (Larchmt); 2018 Oct; 19(7):704-710. PubMed ID: 30227106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy.
    Qi DZ; Lehman K; Dewan K; Kirimanjeswara G; Raman JD
    Int Urol Nephrol; 2018 Jan; 50(1):21-24. PubMed ID: 29170899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute Bacterial Prostatitis: Diagnosis and Management.
    Coker TJ; Dierfeldt DM
    Am Fam Physician; 2016 Jan; 93(2):114-20. PubMed ID: 26926407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positive urine culture prior to transrectal prostate biopsy was not associated with infectious complications development.
    Mrad Dali K; Rahoui M; Chaker K; Ouanes Y; Bibi M; Sellami A; Ben Rhouma S; Nouira Y
    Prog Urol; 2022 Oct; 32(12):830-835. PubMed ID: 35787977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
    Jiang P; Liss MA; Szabo RJ
    J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
    Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
    Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infectious complications after transrectal ultrasound-guided prostatic biopsy. Analysis of our experience.
    Utrera NM; Álvarez MB; Polo JM; Sánchez AT; Martínez JP; González RD
    Arch Esp Urol; 2011 Sep; 64(7):605-10. PubMed ID: 21965258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infection after transrectal ultrasound-guided prostate biopsy.
    Lee SJ
    Korean J Urol; 2015 May; 56(5):346-50. PubMed ID: 25964834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
    Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy?
    Tuncel A; Aslan Y; Sezgin T; Aydin O; Tekdogan U; Atan A
    Urology; 2008 Jun; 71(6):1024-7; discussion 1027-8. PubMed ID: 18400273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones.
    AlKhateeb SS; AlShammari NA; AlZughaibi MA; Ghazwani YG; Alrabeeah KA; Albqami NM
    Saudi Med J; 2016 Aug; 37(8):860-3. PubMed ID: 27464862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
    Drusano GL; Preston SL; Van Guilder M; North D; Gombert M; Oefelein M; Boccumini L; Weisinger B; Corrado M; Kahn J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2046-51. PubMed ID: 10898674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.